Bruce R. Troen, MD, professor of medicine and chief of the Division of Geriatrics and Palliative Medicine, wants people to know that a study published this month in the Annals of Internal Medicine — which shows no benefit from higher doses of vitamin D in the frail elderly — is not the final chapter on how vitamin D affects this population.
Joseph Terrell Smith Jr., PhD, postdoctoral fellow in microbiology and immunology, has been awarded a three-year, $202,000 F32 grant from the National Institute of Allergy and Infectious Diseases to study the regulation of RNA in Trypanosoma brucei.
A fourth-year medical student in the Jacobs School of Medicine and Biomedical Sciences has been selected to participate in the American Medical Association (AMA) Foundation’s 2020-2021 Leadership Development Institute.
A Phase 2 research study led by Teresa Quattrin, MD, UB Distinguished Professor of pediatrics and senior associate dean for research integration, shows that the drug golimumab preserves beta-cell function in children and young adults with newly-diagnosed Type 1 diabetes for at least a year after diagnosis.
Michael W. Russell, PhD, professor emeritus of microbiology and immunology, says more COVID-19 studies should be devoted to how immunity emerges to SARS-CoV-2 in the mucous membranes of the nose and mouth.
Holiday dinner conversations sometimes erupt in heated discussions when friends and relatives with opposing political views get together. This year, whether or not to even host the dinner may be a volatile topic all by itself.
Gil I. Wolfe, MD, UB Distinguished Professor and the Irvin and Rosemary Smith Chair of neurology, served as co-chair for a panel composed of 16 international experts on myasthenia gravis (MG) who revised and expanded recommendations for managing the disease.
Thomas C. Rosenthal, MD, has written a book that examines how doctors dealt with community health crises in earlier times, without the medical advancements and technologies available to researchers in the 21st century.
A study of 24-to-28-month-old mice, the equivalent of 65-to-80-year-old adults, has found that frailty can be slowed with what might be considered “over” supplementation with vitamin D, referred to as “hypersufficiency.”